Table of Contents
How to Start a Wholesale Drug Store Business with Meydan Free Zone
According to Grand View Research¹, the UAE imports 80 percent of its pharmaceutical products. Every tablet dispensed at a pharmacy counter, every vial administered in a hospital, every box of over-the-counter medication stocked on a supermarket shelf arrived in the country through a wholesale distributor.
In a nation with a pharmaceutical sector that imported USD 4.1 billion worth of products in 2020 alone¹, the wholesale layer of the supply chain is a necessity. It is the mechanism through which the UAE's entire health system gets its medicines.
The UAE pharmaceutical market was valued at USD 5.0 billion in 2025, projected to reach USD 8.0 billion by 2033 at a 6.1 percent CAGR, according to Grand View Research¹. IMARC Group² puts the market at USD 4.15 billion in 2024, heading for USD 8.02 billion by 2033 at 7.30 percent CAGR.
The Middle East pharmaceutical market stood at USD 54.28 billion in 2024, growing to USD 78.30 billion by 2033, per Grand View Research³. Statista⁴ notes that, oncology drugs represent the largest therapeutic segment at USD 392.17 million in 2025, followed by diabetes, cardiovascular, and respiratory medications.
The UAE is also emerging as a regional re-export hub: pharmaceutical exports reach USD 1.1 billion in 2020¹, and UAE’s temperature-controlled logistics infrastructure supports GDP-compliant distribution across the GCC, South Asia, and East Africa.
For wholesale traders importing and distributing pharmaceutical products, medical goods, and healthcare consumables, the UAE offers a market where import dependency is structural, healthcare spending is accelerating, and the regulatory environment is modernising to attract international pharmaceutical investment.
Meydan Free Zone offers 100% foreign ownership, zero corporate tax on qualifying income, full profit repatriation, and a fully digital licensing process, providing pharmaceutical wholesalers a base in one of the GCC's fastest-growing and most import-dependent healthcare markets.
Who is this for?
| Audience Segment | Profile |
|---|---|
| Pharmaceutical wholesalers and distributors | |
| OTC and consumer health goods traders | |
| Medical supplies and device wholesalers | |
| Traders importing prescription medicines, branded drugs, generics, and biosimilars from international manufacturers for wholesale distribution to pharmacies, hospital procurement departments, and healthcare groups across the UAE and GCC. | |
| Businesses wholesaling over-the-counter medicines, dietary supplements, vitamins, herbal products, and consumer health goods for supply to pharmacy chains, supermarkets, health food retailers, and e-pharmacy platforms. | |
| Operators importing medical consumables, diagnostic products, wound care supplies, and health-related household goods for distribution to clinics, pharmacies, and institutional healthcare buyers. |
4649.99 - Drug Store
This activity explicitly includes the wholesale of drug store goods (pharmaceutical and medical goods). You are buying and selling pharmaceutical products, medical goods, and health-related consumer products in wholesale quantities for distribution to pharmacies, hospitals, clinics, retailers, and other traders.
This activity covers wholesale trade of pharmaceutical and medical goods only. Manufacturing medicines or medical devices is a production activity.
Dispensing prescriptions or providing pharmacy services to patients is a healthcare service. Selling medicines directly to individual consumers through retail pharmacies or online is retail trade.
This category of wholesale trading excludes wholesale of blank audio and video tapes, CDs and DVDs, wholesale of radio and TV broadcasting equipment, and wholesale of office furniture.
If you are importing pharmaceutical products, medical goods, or health consumables and selling them at wholesale volumes to pharmacies, hospitals, clinics, or other traders, this is your activity. If you are manufacturing medicines, dispensing prescriptions, or selling individual packs to walk-in patients, it is not.
| Category | Scope |
|---|---|
| Prescription medicines | Branded drugs, generics and biosimilars Wholesale of prescription pharmaceuticals including branded drugs, generic equivalents, and biosimilars for distribution to pharmacies, hospital procurement, and healthcare groups. Conventional small-molecule drugs hold 56% of the UAE market1. UAE MARKET CONTEXT According to Towards Healthcare, the UAE has 23 pharmaceutical manufacturing centres producing over 2,500 locally made medicines, yet 80% of products are still imported. |
| OTC and consumer health | Over-the-counter medicines and wellness Import and distribution of OTC medications including pain relief, cold and flu remedies, digestive health, and allergy products for pharmacy chains, supermarkets, and e-pharmacy platforms. Self-medication trends are driving OTC growth. CONSUMER TREND Rising e-pharmacy adoption, digital prescriptions, and health-conscious consumer behaviour are expanding the wholesale addressable market. |
| Supplements and nutraceuticals | Vitamins, supplements and herbal products Trading in vitamins, minerals, dietary supplements, protein products, herbal remedies, and nutraceuticals. Consumer demand for wellness and preventive healthcare is accelerating this segment in the UAE. GROWTH DRIVER International Diabetes Federation reports over 16% of UAE adults live with diabetes, driving sustained demand for long-term management medications and specialty drugs⁶. |
| Medical consumables | Bandages, diagnostics and health supplies Wholesale of medical consumables including bandages, wound care, syringes, gloves, diagnostic test kits, and personal health monitoring devices for supply to clinics, pharmacies, and institutional buyers. TRADE CONTEXT The UAE's GDP-compliant cold-chain infrastructure supports temperature-controlled pharmaceutical distribution across the GCC and beyond. |
Third-Party Approval
This business activity requires third-party approval from the Emirates Drug Establishment prior to obtaining the trading license.
Anti-Money Laundering Compliance
This business activity is exempt from AML compliance requirements.
References
- ¹ Grand View Research — UAE Pharmaceutical Market Size & Outlook (2026–2033) — https://www.grandviewresearch.com/horizon/outlook/pharmaceutical-market/uae
- ² IMARC Group — UAE Pharmaceutical Market Size, Share, Trends and Forecast (2025–2033) — https://www.imarcgroup.com/uae-pharmaceutical-market
- ³ Grand View Research — Middle East Pharmaceutical Market, Industry Report (2025–2033) — https://www.grandviewresearch.com/industry-analysis/middle-east-pharmaceutical-market-report
- ⁴ Statista — Pharmaceuticals Market, United Arab Emirates (2025) — https://www.statista.com/outlook/hmo/pharmaceuticals/united-arab-emirates
- ⁵ Towards Healthcare — Small Molecule CDMO Market Size Expand to $145.12 Bn by 2034 (November 2025) — https://www.towardshealthcare.com/insights/small-molecule-cdmo-market-sizing
- ⁶ International Diabetes Federation — UAE Diabetes Prevalence, cited via Journal of Multidisciplinary Healthcare (2024) — https://www.dovepress.com/current-perspectives-practices-and-barriers-faced-by-community-pharmac-peer-reviewed-fulltext-article-JMDH
